Poon MC - Search Results

1

Therapeutic choices for patients with hemophilia and high-titer inhibitors.

Kulkarni R, Aledort LM, Berntorp E, Brackman HH, Brown D, Cohen AR, Ewing NP, Gringeri A, Gruppo R, Hoots K, Leissenger C, Peerlinck K, Poon MC, Wong WY. Kulkarni R, et al. Among authors: poon mc. Am J Hematol. 2001 Aug;67(4):240-6. doi: 10.1002/ajh.1123. Am J Hematol. 2001. PMID: 11443636 Free article. Review.

2

Comparison of the recovery and half-life of a high-purity factor IX concentrate with those of a factor IX complex concentrate. Factor IX Study Group.

Poon MC, Aledort LM, Anderle K, Kunschak M, Morfini M. Poon MC, et al. Transfusion. 1995 Apr;35(4):319-23. doi: 10.1046/j.1537-2995.1995.35495216081.x. Transfusion. 1995. PMID: 7701550 Clinical Trial.

3

The principal results of the International Immune Tolerance Study: a randomized dose comparison.

Hay CR, DiMichele DM; International Immune Tolerance Study. Hay CR, et al. Blood. 2012 Feb 9;119(6):1335-44. doi: 10.1182/blood-2011-08-369132. Epub 2011 Nov 18. Blood. 2012. PMID: 22101900 Free article. Clinical Trial.

4

Independent adjudicator assessments of platelet refractoriness and rFVIIa efficacy in bleeding episodes and surgeries from the multinational Glanzmann's thrombasthenia registry.

Recht M, Rajpurkar M, Chitlur M, d'Oiron R, Zotz R, Di Minno G, Cooper DL, Poon MC. Recht M, et al. Among authors: poon mc. Am J Hematol. 2017 Jul;92(7):646-652. doi: 10.1002/ajh.24741. Epub 2017 May 9. Am J Hematol. 2017. PMID: 28370369 Free article.

5

Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?

Poon MC. Poon MC. Curr Hematol Rep. 2003 Mar;2(2):139-47. Curr Hematol Rep. 2003. PMID: 12901145 Review.

6

Patients with haemophilia A with inhibitors in China: a national real-world analysis and follow-up.

Dou X, Liu W, Poon MC, Zhang X, Wu J, Zeng X, Wu R, Hu Q, Li C, Wang X, Song X, Chen L, Zhang L, Xue F, Yang R. Dou X, et al. Among authors: poon mc. Br J Haematol. 2021 Mar;192(5):900-908. doi: 10.1111/bjh.17322. Epub 2021 Feb 3. Br J Haematol. 2021. PMID: 33534930

7

Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.

Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y. Poon MC, et al. Semin Hematol. 2006 Jan;43(1 Suppl 1):S33-6. doi: 10.1053/j.seminhematol.2005.11.009. Semin Hematol. 2006. PMID: 16427383 Review.

8

Hemophilia management in transfusion medicine.

Poon MC, Card R. Poon MC, et al. Transfus Apher Sci. 2012 Jun;46(3):299-307. doi: 10.1016/j.transci.2012.03.020. Epub 2012 Apr 13. Transfus Apher Sci. 2012. PMID: 22503305 Review.

9

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.

Mahlangu J, Powell JS, Ragni MV, Chowdary P, Josephson NC, Pabinger I, Hanabusa H, Gupta N, Kulkarni R, Fogarty P, Perry D, Shapiro A, Pasi KJ, Apte S, Nestorov I, Jiang H, Li S, Neelakantan S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Dodd N, Nugent K, Vigliani G, Luk A, Brennan A, Pierce GF; A-LONG Investigators. Mahlangu J, et al. Blood. 2014 Jan 16;123(3):317-25. doi: 10.1182/blood-2013-10-529974. Epub 2013 Nov 13. Blood. 2014. PMID: 24227821 Free PMC article. Clinical Trial.

10

Pharmacokinetic Studies of Factor VIII in Chinese Boys with Severe Hemophilia A: A Single-Center Study.

Chen ZP, Li PJ, Li G, Tang L, Zhen YZ, Wu XY, Cheng XL, Luke KH, Blanchette VS, Poon MC, Ding QL, Wu RH. Chen ZP, et al. Among authors: poon mc. Chin Med J (Engl). 2018 Aug 5;131(15):1780-1785. doi: 10.4103/0366-6999.233604. Chin Med J (Engl). 2018. PMID: 29848837 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page